910 filings
Page 38 of 46
8-K
ARMP
Armata Pharmaceuticals, Inc.
13 Sep 05
Departure of Directors or Principal Officers
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
1 Sep 05
Entry into a Material Definitive Agreement
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
23 Aug 05
Targeted Genetics Announces Todd E. Simpson to Step Down As Chief Financial Officer
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
16 Aug 05
Departure of Directors or Principal Officers
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
28 Jul 05
Results of Operations and Financial Condition
12:00am
10-Q
2005 Q2
ARMP
Armata Pharmaceuticals, Inc.
Quarterly report
28 Jul 05
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
26 Jul 05
TARGETED GENETICS ANNOUNCES PRELIMINARY RESULTS OF PHASE I CLINICAL TRIAL OF tgAAC94 IN PATIENTS WITH INFLAMMATORY ARTHRITIS
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
1 Jun 05
Entry into a Material Definitive Agreement
12:00am
10-Q
2005 Q1
ARMP
Armata Pharmaceuticals, Inc.
Quarterly report
29 Apr 05
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
26 Apr 05
Targeted Genetics Reports First Quarter 2005 Financial Results
12:00am
ARS
2004 FY
ARMP
Armata Pharmaceuticals, Inc.
20 Apr 05
Annual report to shareholders
12:00am
DEF 14A
ARMP
Armata Pharmaceuticals, Inc.
Definitive proxy
14 Apr 05
12:00am
PRE 14A
ARMP
Armata Pharmaceuticals, Inc.
Preliminary proxy
4 Apr 05
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
17 Mar 05
TARGETED GENETICS ANNOUNCES PRELIMINARY RESULTS FROM ITS PHASE II TRIAL OF tgAAVCF IN CYSTIC FIBROSIS
12:00am
10-K
2004 FY
ARMP
Armata Pharmaceuticals, Inc.
Annual report
4 Mar 05
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
3 Mar 05
Results of Operations and Financial Condition
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
23 Feb 05
Targeted Genetics Announces Preliminary Safety Data from Phase I Hiv Vaccine Trial
12:00am
424B5
ARMP
Armata Pharmaceuticals, Inc.
4 Jan 05
Prospectus supplement for primary offering
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
4 Jan 05
Entry into a Material Definitive Agreement
12:00am
424B5
ARMP
Armata Pharmaceuticals, Inc.
4 Jan 05
Prospectus supplement for primary offering
12:00am